Candel Therapeutics, Inc.
CADL
$5.83
$0.122.10%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.80M | 7.38M | -14.07M | -10.65M | -22.24M |
| Total Depreciation and Amortization | 242.00K | 245.00K | 245.00K | 245.00K | 249.00K |
| Total Amortization of Deferred Charges | 32.00K | 44.00K | 52.00K | 62.00K | 73.00K |
| Total Other Non-Cash Items | -4.44M | -14.46M | 7.22M | 2.92M | 15.28M |
| Change in Net Operating Assets | 67.00K | -1.83M | 743.00K | 844.00K | 441.00K |
| Cash from Operations | -8.89M | -8.62M | -5.81M | -6.57M | -6.20M |
| Capital Expenditure | -31.00K | -3.00K | -3.00K | 0.00 | -6.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -31.00K | -3.00K | -3.00K | 0.00 | -6.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.50M | -2.50M | -2.50M | -2.50M | -2.50M |
| Issuance of Common Stock | 19.94M | 630.00K | 94.41M | 4.18M | 4.45M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 17.44M | -1.87M | 91.91M | 1.68M | 1.95M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.52M | -10.49M | 86.10M | -4.90M | -4.26M |